Understanding red blood cell alloimmunization triggers

Author:

Hendrickson Jeanne E.12,Tormey Christopher A.13

Affiliation:

1. Department of Laboratory Medicine and

2. Department of Pediatrics, Yale University School of Medicine, New Haven, CT;

3. Pathology & Laboratory Medicine Service, VA Connecticut Healthcare System, West Haven, CT

Abstract

Abstract Blood group alloimmunization is “triggered” when a person lacking a particular antigen is exposed to this antigen during transfusion or pregnancy. Although exposure to an antigen is necessary for alloimmunization to occur, it is not alone sufficient. Blood group antigens are diverse in structure, function, and immunogenicity. In addition to red blood cells (RBCs), a recipient of an RBC transfusion is exposed to donor plasma, white blood cells, and platelets; the potential contribution of these elements to RBC alloimmunization remains unclear. Much attention in recent years has been placed on recipient factors that influence RBC alloantibody responses. Danger signals, identified in murine and human studies alike as being risk factors for alloimmunization, may be quite diverse in nature. In addition to exogenous or condition-associated inflammation, autoimmunity is also a risk factor for alloantibody formation. Triggers for alloimmunization in pregnancy are not well-understood beyond the presence of a fetal/maternal bleed. Studies using animal models of pregnancy-induced RBC alloimmunization may provide insight in this regard. A better understanding of alloimmunization triggers and signatures of “responders” and “nonresponders” is needed for prevention strategies to be optimized. A common goal of such strategies is increased transfusion safety and improved pregnancy outcomes.

Publisher

American Society of Hematology

Subject

Hematology

Reference42 articles.

1. Red blood cell antibodies in hematology/oncology patients: interpretation of immunohematologic tests and clinical significance of detected antibodies;Hendrickson;Hematol Oncol Clin North Am,2016

2. (FDA) US Department of Health and Human Services. Fatalities reported to the FDA following blood collection. Available at: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability. Accessed August 4, 2016.

3. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series;Nickel;Transfusion,2016

4. Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival;Telen;Transfusion,2015

5. Implications of the Kidd blood group system in renal transplantation;Rourk;Immunohematology,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3